Korea Arlico Pharm Co.,Ltd. (KOSDAQ: 260660)

Korea Arlico Pharm Co.,Ltd. Revenue

Korea Arlico Pharm Co.,Ltd. had revenue of 48.82B KRW in the quarter ending September 30, 2024, with 8.27% growth. This brings the company's revenue in the last twelve months to 182.56B, down -2.27% year-over-year. In the year 2023, Korea Arlico Pharm Co.,Ltd. had annual revenue of 187.15B with 11.58% growth.

• Revenue (ttm): 182.56B
• Revenue Growth: -2.27%
• P/S Ratio: 0.28
• Revenue / Employee: 1.63B
• Employees: 112
• Market Cap: 53.11B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	187.15B	19.42B	11.58%
Dec 31, 2022	167.74B	27.58B	19.68%
Dec 31, 2021	140.16B	15.35B	12.30%
Dec 31, 2020	124.81B	9.02B	7.79%
Dec 31, 2019	115.79B	20.46B	21.46%